Membership
Thank you for choosing to invest in your professional and personal development by subscribing to Health Industry Hub‘s Pharma, MedTech and Biotech news and content.
With over 100,000 industry professionals who accessed the Health Industry Hub content in 2020, we trust that you will also find immense value in the latest industry news, scientific and innovation insights and professional development content.
- For corporate subscriptions, please contact us for a quote that meets the needs of your organisation. Tiered pricing benefits apply.
- Existing registered users with expired access, please subscribe to an annual or monthly subscription by using the link below. Please note terms of use – the content is copyright protected. Under individual licenses, subscribers must not share their username or password with other colleagues to access our subscription content.
- New registered users enjoy the 14 days FREE trial with full access to the latest industry news, scientific and innovation insights and professional development content to connect, engage, inspire and thrive in the Pharma, Biotech and MedTech sectors. No credit card is required. After the trial period, please subscribe to an annual or monthly subscription. Under individual licenses, subscribers must not share their username or password with other colleagues to access our subscription content.
Leadership & Management

The power of being an authentic leader
Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]
MoreDigital & Innovation

Data is the biggest challenge, and opportunity, for MedTech
Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]
MoreNews & Trends - Medical Technology

Thermo Fisher acquisition to better serve its pharma and biotech clients
MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]
MoreNews & Trends - Pharmaceuticals

First-in-class oncology drug candidate licensed by Aussie pharma
Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]
More